Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic.

× No keyword cloud information.

85 in total

1. Discovery of potent 2,4-difluoro-linker poly(ADP-ribose) polymerase 1 inhibitors with enhanced water solubility and in vivo anticancer efficacy.

Authors: Wen-Hua Chen; Shan-Shan Song; Ming-Hui Qi; Xia-Juan Huan; Ying-Qing Wang; Hualiang Jiang; Jian Ding; Guo-Bin Ren; Ze-Hong Miao; Jian Li
Journal: Acta Pharmacol Sin Date: 2017-08-03 Impact factor: 6.150

2. The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy.

Authors: M Javle; N J Curtin
Journal: Ther Adv Med Oncol Date: 2011-11 Impact factor: 8.168

3. Grand challenge commentary: Informative diagnostics for personalized medicine.

Authors: Ryan C Bailey
Journal: Nat Chem Biol Date: 2010-12 Impact factor: 15.040

4. Examination of Diazaspiro Cores as Piperazine Bioisosteres in the Olaparib Framework Shows Reduced DNA Damage and Cytotoxicity.

Authors: Sean W Reilly; Laura N Puentes; Khadija Wilson; Chia-Ju Hsieh; Chi-Chang Weng; Mehran Makvandi; Robert H Mach
Journal: J Med Chem Date: 2018-06-14 Impact factor: 7.446

5. Targeting the missing links for cancer therapy.

Authors: Kornelia Polyak; Judy Garber
Journal: Nat Med Date: 2011-03 Impact factor: 53.440

Review 6. Functions of the poly(ADP-ribose) polymerase superfamily in plants.

Authors: Rebecca S Lamb; Matteo Citarelli; Sachin Teotia
Journal: Cell Mol Life Sci Date: 2011-08-23 Impact factor: 9.261

Review 7. Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics.

Authors: Jin-xue He; Chun-hao Yang; Ze-hong Miao
Journal: Acta Pharmacol Sin Date: 2010-08-02 Impact factor: 6.150

8. Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer.

Authors: X Wen; Z-Q Lin; B Liu; Y-Q Wei
Journal: Cell Prolif Date: 2012-03-20 Impact factor: 6.831

9. Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors.

Authors: Albert A Antolín; Jordi Mestres
Journal: Oncotarget Date: 2014-05-30

10. Preliminary evaluation of a novel ¹⁸F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer.

Authors: Dong Zhou; Jinbin Xu; Cedric Mpoy; Wenhua Chu; Sung Hoon Kim; Huifangjie Li; Buck E Rogers; John A Katzenellenbogen
Journal: Nucl Med Biol Date: 2018-08-24 Impact factor: 2.408